Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimabnin Spain
The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
La utilidad del número necesario de pacientes a largo plazo a tratar para evaluar las terapias inhibidoras de las interleucinas 17 y 23 en el tratamiento de la psoriasis en placas de moderada a grave
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries
Cost Effectiveness Analysis of Tapentadol PR Versus Oxycodone/Naloxone PR in Patients with Musculoskeletal Pain in Spain
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Evaluación y financiación de medicamentos innovadores en España: ¿Dónde estamos y hacia dónde vamos?
Coste-efectividad de la polipíldora CNIC frente a los monocomponentes separados en prevención secundaria cardiovascular en España
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
